Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an ove...
Saved in:
Main Authors: | Anna Karagianni (Author), Maria Malamatari (Author), Kyriakos Kachrimanis (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery
by: Anna Karagianni, et al.
Published: (2018) -
Polyelectrolyte Matrices in the Modulation of Intermolecular Electrostatic Interactions for Amorphous Solid Dispersions: A Comprehensive Review
by: Anastasia Tsiaxerli, et al.
Published: (2021) -
Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation
by: Prabhakar Panzade, et al.
Published: (2017) -
Pharmaceutical cocrystal and their role in improving solid state properties of active pharmaceutical ingredients
by: Ameera A Radhi, et al.
Published: (2023) -
Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems
by: Maan Singh, et al.
Published: (2023)